TxCell teams to develop CAR-T-based cell therapy for rare skin disease
TxCell will develop a CAR-T-based treatment for a rare autoimmune skin disease called bullous pemphigoid in collaboration with researchers at the University of Lubeck in Germany.
Archives for June 2, 2016
Ten of the best? US FDA asks biologics makers to submit possible INN suffixes
The US FDA has updated its draft nonproprietary naming guidance allowing drugmakers to submit up to 10 suffixes for each new biologic and biosimilar product.
Breaking the single-use paradigm? CMC Biologics to offer 12,000L scale runs
Single-use manufacturing runs have been limited to 2,000L, but CMC Biologics says it will be able to offer 12,000L of commercial scale through its bioreactor configuration platform.